Literature DB >> 16784070

Gender-related differences in left ventricular remodeling in chronic severe aortic valve regurgitation in rats.

Marie-Claude Drolet1, Dominic Lachance, Eric Plante, Elise Roussel, Jacques Couet, Marie Arsenault.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Aortic valve regurgitation (AR) can result in heart failure from chronic overloading of the left ventricle. As little is known of gender-specific responses of the left ventricle to this condition, the study aim was to compare left ventricular (LV) remodeling in male and female rats with severe AR. In order to assess the impact of estrogens on LV remodeling in AR, the effect of ovariectomy (OVX) was also evaluated.
METHODS: AR was created in adult Wistar rats (females (control or OVX) and males). Animals were followed for 26 weeks and compared to sham-operated groups. Heart function was evaluated in vivo using echocardiography, and the hearts were subsequently harvested for tissue analysis.
RESULTS: The LV ejection fraction was decreased similarly in both sexes. Despite similar echocardiographic AR severity, females had higher indexed cardiac output and the largest increase in LV weight, cardiomyocyte hypertrophy and eccentric remodeling. No differences were observed between control and OVX females. Ovariectomy had no significant impact on any of the parameters monitored.
CONCLUSION: Female rats developed more LV remodeling in response to chronic AR than males. AR appears to impose a greater LV workload on females due to their smaller body and heart size. Hormonal status did not have any impact on LV remodeling in this experimental model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784070

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  8 in total

Review 1.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

Review 2.  Gender Differences in Cardiac Hypertrophy.

Authors:  Jian Wu; Fangjie Dai; Chang Li; Yunzeng Zou
Journal:  J Cardiovasc Transl Res       Date:  2019-08-15       Impact factor: 4.132

3.  Evaluation of early bilateral ovariectomy in mice as a model of left heart disease.

Authors:  J Ethan Joll; Matthew R Bersi; Jeffry S Nyman; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-04-29       Impact factor: 5.125

4.  Signaling responses after exposure to 5 alpha-dihydrotestosterone or 17 beta-estradiol in norepinephrine-induced hypertrophy of neonatal rat ventricular myocytes.

Authors:  Yevgeniya E Koshman; Mariann R Piano; Brenda Russell; Dorie W Schwertz
Journal:  J Appl Physiol (1985)       Date:  2009-12-31

5.  Female rats with severe left ventricle volume overload exhibit more cardiac hypertrophy but fewer myocardial transcriptional changes than males.

Authors:  Catherine Beaumont; Élisabeth Walsh-Wilkinson; Marie-Claude Drolet; Élise Roussel; Marie Arsenault; Jacques Couet
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

6.  Sex differences in the response to angiotensin II receptor blockade in a rat model of eccentric cardiac hypertrophy.

Authors:  Élisabeth Walsh-Wilkinson; Marie-Claude Drolet; Charlie Le Houillier; Ève-Marie Roy; Marie Arsenault; Jacques Couet
Journal:  PeerJ       Date:  2019-08-05       Impact factor: 2.984

7.  Sex differences in the evolution of left ventricle remodeling in rats with severe volume overload.

Authors:  Elisabeth Walsh-Wilkinson; Marie-Claude Drolet; Marie Arsenault; Jacques Couet
Journal:  BMC Cardiovasc Disord       Date:  2020-02-03       Impact factor: 2.298

8.  Effects of the loss of estrogen on the heart's hypertrophic response to chronic left ventricle volume overload in rats.

Authors:  Elisabeth Walsh-Wilkinson; Catherine Beaumont; Marie-Claude Drolet; Ève-Marie Roy; Charlie Le Houillier; Jonathan Beaudoin; Marie Arsenault; Jacques Couet
Journal:  PeerJ       Date:  2019-10-21       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.